Molecular profiling of meningioma can lead to improved prognosis and therapy
Reliably predicting whether meningioma, the most common primary brain tumor, will recur or remain benign has not been easy. In this study, published in Science Advances, researchers at Baylor College of Medicine and the Jan ...
Feb 2, 2022
0
65